BetterLife Pharma (BETRF) Intangibles (2017 - 2026)
BetterLife Pharma (BETRF) posted quarterly Intangibles of $9.0 million for Q1 2026, down 2.82% year-over-year from $9.3 million in Q1 2025, and down 2.82% quarter-over-quarter from $9.3 million in Q1 2025.
BetterLife Pharma (BETRF) Intangibles (2017 - 2026) Analysis & Trends
BetterLife Pharma's Intangibles history runs 10 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Intangibles fell 2.82% year-over-year to $9.0 million; the TTM figure through Jan 2026 stood at $9.0 million (down 2.82% YoY), while the FY2026 annual figure was $9.0 million, down 2.82% from the prior year.
- Intangibles for Q1 2026 stood at $9.0 million, down from $9.3 million in the prior quarter.
- The five-year high for Intangibles was $12.1 million in Q1 2022, with the low at $9.0 million in Q1 2026.
- The 5-year median for Intangibles is $10.3 million (2024), against an average of $10.3 million.
- The sharpest annual moves came in 2022 and 2026: Intangibles dropped 10.76% in 2022, then retreated 2.82% in 2026.
- BetterLife Pharma's Intangibles stood at $12.1 million in 2022, then slipped by 10.69% to $10.8 million in 2023, then decreased by 5.21% to $10.3 million in 2024, then declined by 9.53% to $9.3 million in 2025, then declined by 2.82% to $9.0 million in 2026.
- Business Quant data shows BETRF's Intangibles at $9.0 million in Q1 2026, $9.3 million in Q1 2025, and $10.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 9.02 Mn |
| Jan 31, 2025 | 9.28 Mn |
| Jan 31, 2024 | 10.26 Mn |
| Jan 31, 2023 | 10.82 Mn |
| Jan 31, 2022 | 12.12 Mn |
| Jan 31, 2021 | 13.58 Mn |
| Oct 31, 2020 | 8.59 Mn |
| Jul 31, 2020 | 586,650.90 |
| Apr 30, 2020 | 615,514.80 |
| Jan 31, 2020 | 873,366.95 |
| Oct 31, 2019 | 5.76 Mn |
| Jul 31, 2019 | 5.92 Mn |
| Apr 30, 2019 | 6.21 Mn |
| Jan 31, 2019 | 6.98 Mn |
| Oct 31, 2018 | 6.52 Mn |
| Jul 31, 2018 | 6.71 Mn |
| Apr 30, 2018 | 6.95 Mn |
| Jan 31, 2018 | 252,184.92 |
| Jan 31, 2017 | 234,564.00 |